SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001102624-14-000532
Filing Date
2014-04-04
Accepted
2014-04-04 14:18:34
Documents
1
Period of Report
2014-02-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3613
  Complete submission text file 0001102624-14-000532.txt   5079
Mailing Address C/O AXONYX INC 500 SEVENTH AVE 1OTH FLOOR NEW YORK NY 10018
Business Address
NEILL SYDNEY COLIN (Reporting) CIK: 0001263844 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54586 | Film No.: 14745465

Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
Boston Therapeutics, Inc. (Issuer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations